These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20032783)

  • 1. HIV replication capacity is an independent predictor of disease progression in persons with untreated chronic HIV infection.
    Goetz MB; Leduc R; Wyman N; Kostman JR; Labriola AM; Lie Y; Weidler J; Coakley E; Bates M; Luskin-Hawk R;
    J Acquir Immune Defic Syndr; 2010 Apr; 53(4):472-9. PubMed ID: 20032783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between HIV coreceptor tropism and disease progression in persons with untreated chronic HIV infection.
    Goetz MB; Leduc R; Kostman JR; Labriola AM; Lie Y; Weidler J; Coakley E; Bates M; Luskin-Hawk R;
    J Acquir Immune Defic Syndr; 2009 Mar; 50(3):259-66. PubMed ID: 19194318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progression.
    Ng OT; Laeyendecker O; Redd AD; Munshaw S; Grabowski MK; Paquet AC; Evans MC; Haddad M; Huang W; Robb ML; Reynolds SJ; Gray RH; Wawer MJ; Serwadda D; Eshleman SH; Quinn TC
    J Infect Dis; 2014 Jan; 209(1):66-73. PubMed ID: 23922373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection.
    Barbour JD; Hecht FM; Wrin T; Segal MR; Ramstead CA; Liegler TJ; Busch MP; Petropoulos CJ; Hellmann NS; Kahn JO; Grant RM
    J Infect Dis; 2004 Jul; 190(2):251-6. PubMed ID: 15216458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
    Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
    Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure.
    De Luca A; Weidler J; Di Giambenedetto S; Coakley E; Cingolani A; Bates M; Lie Y; Pesano R; Cauda R; Schapiro J
    J Acquir Immune Defic Syndr; 2007 Aug; 45(4):411-7. PubMed ID: 17554216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
    Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
    Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
    Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ
    N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1.
    Emu B; Fessel J; Schrader S; Kumar P; Richmond G; Win S; Weinheimer S; Marsolais C; Lewis S
    N Engl J Med; 2018 Aug; 379(7):645-654. PubMed ID: 30110589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 pol replication capacity predicts disease progression.
    Daar ES; Kesler KL; Wrin T; Petropoulo CJ; Bates M; Lail A; Hellmann NS; Gomperts E; Donfield S;
    AIDS; 2005 Jun; 19(9):871-7. PubMed ID: 15905667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trial of three antiretroviral regimens in HIV-1-infected children.
    Luzuriaga K; McManus M; Mofenson L; Britto P; Graham B; Sullivan JL;
    N Engl J Med; 2004 Jun; 350(24):2471-80. PubMed ID: 15190139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
    AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.
    Potter M; Odueyungbo A; Yang H; Saeed S; Klein MB;
    AIDS; 2010 Jul; 24(12):1857-65. PubMed ID: 20479633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.
    De Luca A; Marazzi MC; Mancinelli S; Ceffa S; Altan AM; Buonomo E; Prosperi MC; Pedruzzi B; Noorjehan AM; Scarcella P; Liotta G; Palombi L
    J Acquir Immune Defic Syndr; 2012 Mar; 59(3):236-44. PubMed ID: 22327246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of influenza vaccination on disease progression among HIV-infected persons.
    Sullivan PS; Hanson DL; Dworkin MS; Jones JL; Ward JW;
    AIDS; 2000 Dec; 14(17):2781-5. PubMed ID: 11125897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study.
    Erb P; Battegay M; Zimmerli W; Rickenbach M; Egger M
    Arch Intern Med; 2000 Apr; 160(8):1134-40. PubMed ID: 10789606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidémiologie du SIDA en Aquitaine (GECSA).
    Thiébaut R; Morlat P; Jacqmin-Gadda H; Neau D; Mercié P; Dabis F; Chêne G
    AIDS; 2000 May; 14(8):971-8. PubMed ID: 10853978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.